insights_auto
Why is NXTCL down 2.59%?
Dive Deeperchevron_right
NXTCL:STO
NextCell Pharma AB
SEK 0.98
arrow_downward
-2.59%(-0.026) 1D
Oct 20, 3:43:28 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NXTCL...
Open
SEK 0.99
High
SEK 1.01
Low
SEK 0.95
Mkt. cap
124.11M
Avg. vol.
369.66K
Volume
95.09K
52-wk high
SEK 1.78
52-wk low
SEK 0.63
EPS
-SEK 0.45
Shares outstanding
111.39M
No. of employees
21
Open
SEK 0.99
High
SEK 1.01
Low
SEK 0.95
Mkt. cap
124.11M
Avg. vol.
369.66K
Volume
95.09K
52-wk high
SEK 1.78
52-wk low
SEK 0.63
EPS
-SEK 0.45
Shares outstanding
111.39M
No. of employees
21
News stories
From web sources and news partners
Forbes
·
16 minutes ago
Could Inflation Sink S&P 40%?
FOREX.com
·
1 hour ago
USD/JPY and Nasdaq Price Outlook: Key Levels to Watch
TradingView
·
43 minutes ago
S&P 500 stalls near records; Key levels in focus
Traders Union
·
33 minutes ago
S&P 500 tests key support as traders weigh risk of deeper pullback
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees21
FoundedMar 19, 2014
Headquarters-
SectorBiotechnology
Websitenextcellpharma.com